ClinicalTrials.govrestricted
Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01069328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ShareScore
20/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 4
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 4